DC Field | Value | Language |
---|---|---|
dc.contributor.author | C Lee | - |
dc.contributor.author | E Choi | - |
dc.contributor.author | M Cho | - |
dc.contributor.author | B Lee | - |
dc.contributor.author | Soo Jin Oh | - |
dc.contributor.author | S K Park | - |
dc.contributor.author | K Lee | - |
dc.contributor.author | H M Kim | - |
dc.contributor.author | G Han | - |
dc.date.accessioned | 2017-04-19T09:30:19Z | - |
dc.date.available | 2017-04-19T09:30:19Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | 10.1016/j.bmcl.2012.04.045 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/10744 | - |
dc.description.abstract | Histone deacetylases (HDACs) are involved in post-translational modification and epi-genetic expression, and have been the intriguing targets for treatment of cancer. In previous study, we reported synthesis and the biological preliminary results of γ-lactam based HDAC inhibitors. Based on the previous results, smaller γ-lactam core HDAC inhibitors are more active than the corresponding series of larger δ-lactam based analogues and the hydrophobic and bulky cap groups are required for better potency which decreased microsomal stability. Thus, γ-lactam analogues with methoxy, trifluoromethyl groups of ortho-, meta-, para-positions of cap group were prepared and evaluated their biological potency. Among them, trifluoromethyl analogues, which have larger lipophilicity, showed better HDAC inhibitory activity than other analogues. In overall, lipophilicity leads to increase hydrophobic interaction between surface of HDAC active site and HDAC inhibitor, improves HDAC inhibitory activity. | - |
dc.publisher | Elsevier | - |
dc.title | Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: Part II | - |
dc.title.alternative | Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: Part II | - |
dc.type | Article | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.number | 12 | - |
dc.citation.endPage | 4192 | - |
dc.citation.startPage | 4189 | - |
dc.citation.volume | 22 | - |
dc.contributor.affiliatedAuthor | Soo Jin Oh | - |
dc.contributor.alternativeName | 이철호 | - |
dc.contributor.alternativeName | 최은현 | - |
dc.contributor.alternativeName | 조미선 | - |
dc.contributor.alternativeName | 이보아 | - |
dc.contributor.alternativeName | 오수진 | - |
dc.contributor.alternativeName | 박성규 | - |
dc.contributor.alternativeName | 이기호 | - |
dc.contributor.alternativeName | 김환묵 | - |
dc.contributor.alternativeName | 한균희 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 12, pp. 4189-4192 | - |
dc.identifier.doi | 10.1016/j.bmcl.2012.04.045 | - |
dc.subject.keyword | Docking | - |
dc.subject.keyword | Histone deacetylases | - |
dc.subject.keyword | Inhibitor | - |
dc.subject.keyword | Optimization | - |
dc.subject.keyword | Property | - |
dc.subject.local | docking | - |
dc.subject.local | Docking | - |
dc.subject.local | Histone deacetylase | - |
dc.subject.local | histone deacetylase (HDAC) | - |
dc.subject.local | Histone deacetylases | - |
dc.subject.local | histone deacetylase | - |
dc.subject.local | inhibitors | - |
dc.subject.local | Inhibitors | - |
dc.subject.local | inhibitor | - |
dc.subject.local | Inhibitor | - |
dc.subject.local | optimization | - |
dc.subject.local | Optimization | - |
dc.subject.local | property | - |
dc.subject.local | Properties | - |
dc.subject.local | Property | - |
dc.subject.local | properties | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.